| Title | Journal of Labelled Compounds and Radiopharmaceuticals |
| Abbreviation | J. Label. Compd. Radiopharm. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3) |
| h-index | 51 |
| Overall Rank/Ranking | 11568 |
| SCImago Journal Rank (SJR) | 0.440 |
| Impact Score | 1.66 |
| Publisher | John Wiley and Sons Ltd |
| Country | United Kingdom |
| ISSN | 03624803, 10991344 |
| Best Quartile | Q2 |
| Coverage History | 1976-2022 |
The Official Journal of the International Isotope Society
The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research in labelled compound preparation and application. This includes areas such as analytical control, self radiolysis, quality control handling, storage, and tracer methods used in chemical, biochemical, biological, pharmacological, medical, genetic, agricultural and geochemical research. All radionuclides and enriched stable nuclides are included.
Journal of Labelled Compounds and Radiopharmaceuticals is a journal covering the technologies/fields/categories related to Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3). It is published by John Wiley and Sons Ltd. The overall rank of Journal of Labelled Compounds and Radiopharmaceuticals is 11568. According to SCImago Journal Rank (SJR), this journal is ranked 0.440. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 51. The best quartile for this journal is Q2.
The ISSN of Journal of Labelled Compounds and Radiopharmaceuticals journal is 03624803, 10991344. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Labelled Compounds and Radiopharmaceuticals is cited by a total of 337 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Journal of Labelled Compounds and Radiopharmaceuticals is 1.66, which is computed in 2023 as per its definition. Journal of Labelled Compounds and Radiopharmaceuticals IF is decreased by a factor of 0.06 and approximate percentage change is -3.49% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Journal of Labelled Compounds and Radiopharmaceuticals is 1.66. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.66 |
| 2021 | 1.72 |
| 2020 | 1.66 |
| 2019 | 1.52 |
| 2018 | 1.15 |
| 2017 | 1.27 |
| 2016 | 1.75 |
| 2015 | 1.47 |
| 2014 | 1.13 |
Journal of Labelled Compounds and Radiopharmaceuticals has an h-index of 51. It means 51 articles of this journal have more than 51 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Labelled Compounds and Radiopharmaceuticals is 03624803, 10991344. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Labelled Compounds and Radiopharmaceuticals is 11568. According to SCImago Journal Rank (SJR), this journal is ranked 0.440. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.440 |
| 2021 | 0.468 |
| 2020 | 0.432 |
| 2019 | 0.468 |
| 2018 | 0.359 |
| 2017 | 0.477 |
| 2016 | 0.603 |
| 2015 | 0.459 |
| 2014 | 0.372 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 11568 |
| 2021 | 10629 |
| 2020 | 11390 |
| 2019 | 10399 |
| 2018 | 12208 |
| 2017 | 9580 |
| 2016 | 7818 |
| 2015 | 9871 |
| 2014 | 11211 |
Journal of Labelled Compounds and Radiopharmaceuticals is published by John Wiley and Sons Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1976-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Labelled Compounds and Radiopharmaceuticals is J. Label. Compd. Radiopharm.. This abbreviation ('J. Label. Compd. Radiopharm.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Labelled Compounds and Radiopharmaceuticals latest impact IF is 1.66. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.75 (2016) and 1.13 (2014), respectively, in the last 9 years. Moreover, its average IS is 1.48 in the previous 9 years.
The Journal of Labelled Compounds and Radiopharmaceuticals has an SJR (SCImago Journal Rank) of 0.440, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.603 in 2016 and the lowest being 0.359 in 2018. Furthermore, the average SJR of the Journal of Labelled Compounds and Radiopharmaceuticals over the previous 9-year period stands at 1.48.
The latest h-index of the Journal of Labelled Compounds and Radiopharmaceuticals is 51.
The Journal of Labelled Compounds and Radiopharmaceuticals is published by the John Wiley and Sons Ltd, with its country of publication being the United Kingdom.
The Journal of Labelled Compounds and Radiopharmaceuticals is currently ranked 11568 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 7818 in 2016 and its lowest position of 12208 in 2018.
The standard ISO4 abbreviation for the Journal of Labelled Compounds and Radiopharmaceuticals is J. Label. Compd. Radiopharm..
Journal of Labelled Compounds and Radiopharmaceuticals is classified as a journal that the John Wiley and Sons Ltd publishes.
The Journal of Labelled Compounds and Radiopharmaceuticals encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Labelled Compounds and Radiopharmaceuticals is assigned the following International Standard Serial Numbers (ISSN): 03624803, 10991344.
The best quartile for the Journal of Labelled Compounds and Radiopharmaceuticals is Q2 (2022).
The Journal of Labelled Compounds and Radiopharmaceuticals coverage history can be summarized as follows: 1976-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Journal of Education and Work | journal | 9268 | Brill Academic Publishers | 43 | 1.93 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 25369 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
| Museum Management and Curatorship | journal | 8168 | Routledge | 37 | 2.65 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.66 |
| 2021 | 1.72 |
| 2020 | 1.66 |
| 2019 | 1.52 |
| 2018 | 1.15 |
| 2017 | 1.27 |
| 2016 | 1.75 |
| 2015 | 1.47 |
| 2014 | 1.13 |
